Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1996-10-4
|
pubmed:abstractText |
Short-acting beta 2 agonists have a rapid and potent bronchodilating effect and represent the basis of treatment of acute asthma. Whatever the level of severity, the inhaled route is preferred because of its high efficacy/tolerance ratio. The doses and modes of administration depend on the severity of the airway obstruction, the site of management and the available devices. Long-acting beta 2 agonists are administered as regular treatment in moderately-severe to severe chaonic asthma in association to inhaled corticosteroids, mainly by the inhaled route whereas the oral route may be considered for the administration of prodrugs.
|
pubmed:language |
fre
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0761-8417
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
52
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
119-27
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8761642-Administration, Inhalation,
pubmed-meshheading:8761642-Administration, Oral,
pubmed-meshheading:8761642-Adrenergic beta-Agonists,
pubmed-meshheading:8761642-Asthma,
pubmed-meshheading:8761642-Humans,
pubmed-meshheading:8761642-Injections, Intravenous,
pubmed-meshheading:8761642-Injections, Subcutaneous
|
pubmed:year |
1996
|
pubmed:articleTitle |
[Modes of administration of beta agonists in asthma].
|
pubmed:affiliation |
Service de Médecine Interne, Centre Hospitalier Universitaire Bicêtre, Le Kremlin Bicêtre.
|
pubmed:publicationType |
Journal Article,
English Abstract,
Review
|